ZGNX Share Price

Open 10.70 Change Price %
High 10.85 1 Day 0.00 0.00
Low 10.50 1 Week 0.40 3.88
Close 10.70 1 Month 0.35 3.38
Volume 95284 1 Year -0.93 -8.00
52 Week High 13.70
52 Week Low 7.33
ZGNX Important Levels
Resistance 2 11.02
Resistance 1 10.89
Pivot 10.68
Support 1 10.51
Support 2 10.38
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
SIRI 5.07 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
ESSX 0.22 69.23%
MYRX 0.08 60.00%
CGEI 0.35 59.09%
LOCM 0.09 50.00%
RITT 0.03 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CARV 4.90 22.81%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Zogenix, Inc. (NASDAQ: ZGNX)

ZGNX Technical Analysis 4
As on 21st Apr 2017 ZGNX Share Price closed @ 10.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 10.01 & Strong Buy for SHORT-TERM with Stoploss of 10.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
ZGNX Target for April
1st Target up-side 12.43
2nd Target up-side 13.54
3rd Target up-side 14.65
1st Target down-side 9.27
2nd Target down-side 8.16
3rd Target down-side 7.05
ZGNX Other Details
Segment EQ
Market Capital 232515696.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.zogenix.com
ZGNX Address
ZGNX
12400 High Bluff Drive
Suite 650
San Diego, CA 92130
United States
Phone: 858-259-1165
Fax: 858-259-1166
ZGNX Latest News
Investor Toolkit: A look at Zogenix, Inc. (NasdaqGM:ZGNX)'s Margin Score   Buckeye Business Review   - 21st Apr 17
What is the Street Saying About Zogenix, Inc. (NASDAQ:ZGNX)?   Aiken Advocate   - 20th Apr 17
Insider Buying: Zogenix, Inc. (ZGNX) Director Purchases 5000 Shares of Stock   The Cerbat Gem   - 20th Apr 17
Zogenix Inc. (ZGNX) Plunges 5.09% on March 13   Equities.com   - 14th Mar 17
Zogenix Is On The Precipice Of Substantial Growth - Part 2   Seeking Alpha   - 08th Mar 17
Zogenix Is On The Precipice Of Substantial Growth   Seeking Alpha   - 24th Feb 17
Zogenix Announces Issuance of US Patent for ZX008 in Dravet Syndrome   GlobeNewswire (press release)   - 30th Jan 17
Zogenix Announces CFO Transition   GlobeNewswire (press release)   - 06th Jan 17
Why Zogenix, Inc. Shares Rocketed 22% Higher in May   Motley Fool   - 05th Jun 15
Zogenix Inc. Shares Crumbled in March -- Here's Why   Motley Fool   - 10th Apr 15
Interactive Technical Analysis Chart Zogenix, Inc. ( ZGNX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Zogenix, Inc.
ZGNX Business Profile
Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company�s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, Zohydro (hydrocodone bitartrate, formerly ZX002) is a 12-hour extended-release formulation of hydrocodone without acetaminophen for the treatment of chronic pain requiring opioid therapy. It completed Phase 3 development of Zohydro in 2011. Sumavel DosePro and Zohydro are used for the treatment options available to patients and physicians in the United States. Its second DosePro investigational product candidate, Relday, is a injectable formulation of risperidone for the treatment of schizophrenia. In May, 2012, it submitted a New Drug Application to the Food and Drug Administration (FDA).